Trial Profile
Evaluation of the ReNu Amniotic Suspension Allograft After Marrow Stimulation in the Treatment of Osteochondral Defects
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 13 Jan 2020 Status changed from recruiting to discontinued.
- 15 May 2019 Planned End Date changed from 1 Oct 2019 to 1 May 2022.
- 15 May 2019 Planned primary completion date changed from 1 Oct 2019 to 1 May 2022.